- Home
- BMRN vs GIB Comparison
BMRN vs GIB Comparison
Compare BMRN & GIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | GIB |
|---|---|---|
| Founded | 1996 | 1976 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 12.8B |
| IPO Year | 1999 | 1999 |
Fundamental Metrics
Financial Performance| Metric | BMRN | GIB |
|---|---|---|
| Price | $60.82 | $69.28 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 3 |
| Target Price | $88.22 | ★ $112.00 |
| AVG Volume (30 Days) | ★ 1.5M | 378.3K |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $15.02 | $8.33 |
| Revenue Next Year | $12.23 | $2.96 |
| P/E Ratio | $109.87 | ★ $13.59 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $49.26 | $59.63 |
| 52 Week High | $66.28 | $103.04 |
Technical Indicators
Market Signals| Indicator | BMRN | GIB |
|---|---|---|
| Relative Strength Index (RSI) | 63.18 | 59.90 |
| Support Level | $54.24 | $60.78 |
| Resistance Level | $61.92 | $71.78 |
| Average True Range (ATR) | 1.40 | 1.80 |
| MACD | -0.07 | 0.15 |
| Stochastic Oscillator | 96.63 | 96.81 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About GIB CGI Inc.
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.